Top Story

VIDEO: Antiplatelet, anticoagulant therapies similarly effective for carotid, vertebral artery dissection

March 6, 2015

NASHVILLE, Tenn. — Larry B. Goldstein, MD, FAAN, FANA, FAHA, professor of neurology and director of the Stroke Center at Duke University and Cardiology Today Editorial Board member, discusses a study presented at the International Stroke Conference that compared use of anticoagulant and antiplatelet therapies among patients with a carotid or vertebral artery dissection.

Goldstein said treatment of these patients has been uncertain. Some prior data have indicated that antiplatelet therapies such as aspirin or clopidogrel would be sufficient treatment options, while other studies have suggested the benefits of anticoagulants such as heparin followed by warfarin.

Meeting News Coverage

Excess sedentary time raises risk for coronary artery calcification

March 6, 2015
The more time spent sedentary each day was associated with increased risk for coronary artery calcification, according to a new report.However, reduction of sedentary…
In the Journals

RAUST: Ultrasound guidance facilitates transradial access

March 6, 2015
Real-time ultrasound guidance was associated with improved success and efficiency of radial artery cannulation in patients who presented for transradial cardiac…
Maura M. Zylla, MD In the Journals

Intracardiac thrombi rates lower with dabigatran, rivaroxaban, compared with phenprocoumon

March 6, 2015
The prevalence of intracardiac thrombi was lower in high-risk patients with atrial fibrillation and flutter treated with direct oral anticoagulants compared with…
In the Journals

Moderate coffee consumption may lower risk for subclinical coronary atherosclerosis

March 6, 2015
Healthy adults in Korea who drank three to five cups of coffee per day had lower risk for subclinical coronary atherosclerosis compared with higher and lower…
More News Headlines »
CME
Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

More »
Meeting News Coverage Video
thumbnail for video 4083453350001

Video: Action needed to reduce CVD risks in HIV patients

February 28, 2015
SEATTLE — Steven Grinspoon, MD, of the Massachusetts General Hospital and Harvard Medical School, gives an…
More »
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »
morganatic-roan
morganatic-roan